Genomic Instability in Multiple Myeloma: A “Non-Coding RNA” Perspective

Multiple myeloma (MM) is a complex hematological malignancy characterized by abnormal proliferation of malignant plasma cells (PCs) within a permissive bone marrow microenvironment. The pathogenesis of MM is unequivocally linked to the acquisition of genomic instability (GI), which indicates the ten...

Full description

Bibliographic Details
Main Authors: Elisa Taiana, Maria Eugenia Gallo Cantafio, Vanessa Katia Favasuli, Cecilia Bandini, Giuseppe Viglietto, Roberto Piva, Antonino Neri, Nicola Amodio
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/9/2127
_version_ 1797535984189964288
author Elisa Taiana
Maria Eugenia Gallo Cantafio
Vanessa Katia Favasuli
Cecilia Bandini
Giuseppe Viglietto
Roberto Piva
Antonino Neri
Nicola Amodio
author_facet Elisa Taiana
Maria Eugenia Gallo Cantafio
Vanessa Katia Favasuli
Cecilia Bandini
Giuseppe Viglietto
Roberto Piva
Antonino Neri
Nicola Amodio
author_sort Elisa Taiana
collection DOAJ
description Multiple myeloma (MM) is a complex hematological malignancy characterized by abnormal proliferation of malignant plasma cells (PCs) within a permissive bone marrow microenvironment. The pathogenesis of MM is unequivocally linked to the acquisition of genomic instability (GI), which indicates the tendency of tumor cells to accumulate a wide repertoire of genetic alterations. Such alterations can even be detected at the premalignant stages of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) and, overall, contribute to the acquisition of the malignant traits underlying disease progression. The molecular basis of GI remains unclear, with replication stress and deregulation of DNA damage repair pathways representing the most documented mechanisms. The discovery that non-coding RNA molecules are deeply dysregulated in MM and can target pivotal components of GI pathways has introduced a further layer of complexity to the GI scenario in this disease. In this review, we will summarize available information on the molecular determinants of GI in MM, focusing on the role of non-coding RNAs as novel means to tackle GI for therapeutic intervention.
first_indexed 2024-03-10T11:53:08Z
format Article
id doaj.art-7d63a1dc07cd48b9bccee99dd8f1b641
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T11:53:08Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-7d63a1dc07cd48b9bccee99dd8f1b6412023-11-21T17:33:47ZengMDPI AGCancers2072-66942021-04-01139212710.3390/cancers13092127Genomic Instability in Multiple Myeloma: A “Non-Coding RNA” PerspectiveElisa Taiana0Maria Eugenia Gallo Cantafio1Vanessa Katia Favasuli2Cecilia Bandini3Giuseppe Viglietto4Roberto Piva5Antonino Neri6Nicola Amodio7Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, ItalyDepartment of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100 Catanzaro, ItalyDepartment of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, ItalyDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, ItalyDepartment of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100 Catanzaro, ItalyDepartment of Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, ItalyDepartment of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, ItalyDepartment of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100 Catanzaro, ItalyMultiple myeloma (MM) is a complex hematological malignancy characterized by abnormal proliferation of malignant plasma cells (PCs) within a permissive bone marrow microenvironment. The pathogenesis of MM is unequivocally linked to the acquisition of genomic instability (GI), which indicates the tendency of tumor cells to accumulate a wide repertoire of genetic alterations. Such alterations can even be detected at the premalignant stages of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) and, overall, contribute to the acquisition of the malignant traits underlying disease progression. The molecular basis of GI remains unclear, with replication stress and deregulation of DNA damage repair pathways representing the most documented mechanisms. The discovery that non-coding RNA molecules are deeply dysregulated in MM and can target pivotal components of GI pathways has introduced a further layer of complexity to the GI scenario in this disease. In this review, we will summarize available information on the molecular determinants of GI in MM, focusing on the role of non-coding RNAs as novel means to tackle GI for therapeutic intervention.https://www.mdpi.com/2072-6694/13/9/2127multiple myelomaDNA repairgenomic instabilityDNA damage responsebase excision repairhomologous recombination
spellingShingle Elisa Taiana
Maria Eugenia Gallo Cantafio
Vanessa Katia Favasuli
Cecilia Bandini
Giuseppe Viglietto
Roberto Piva
Antonino Neri
Nicola Amodio
Genomic Instability in Multiple Myeloma: A “Non-Coding RNA” Perspective
Cancers
multiple myeloma
DNA repair
genomic instability
DNA damage response
base excision repair
homologous recombination
title Genomic Instability in Multiple Myeloma: A “Non-Coding RNA” Perspective
title_full Genomic Instability in Multiple Myeloma: A “Non-Coding RNA” Perspective
title_fullStr Genomic Instability in Multiple Myeloma: A “Non-Coding RNA” Perspective
title_full_unstemmed Genomic Instability in Multiple Myeloma: A “Non-Coding RNA” Perspective
title_short Genomic Instability in Multiple Myeloma: A “Non-Coding RNA” Perspective
title_sort genomic instability in multiple myeloma a non coding rna perspective
topic multiple myeloma
DNA repair
genomic instability
DNA damage response
base excision repair
homologous recombination
url https://www.mdpi.com/2072-6694/13/9/2127
work_keys_str_mv AT elisataiana genomicinstabilityinmultiplemyelomaanoncodingrnaperspective
AT mariaeugeniagallocantafio genomicinstabilityinmultiplemyelomaanoncodingrnaperspective
AT vanessakatiafavasuli genomicinstabilityinmultiplemyelomaanoncodingrnaperspective
AT ceciliabandini genomicinstabilityinmultiplemyelomaanoncodingrnaperspective
AT giuseppeviglietto genomicinstabilityinmultiplemyelomaanoncodingrnaperspective
AT robertopiva genomicinstabilityinmultiplemyelomaanoncodingrnaperspective
AT antoninoneri genomicinstabilityinmultiplemyelomaanoncodingrnaperspective
AT nicolaamodio genomicinstabilityinmultiplemyelomaanoncodingrnaperspective